Trial Profile
A Phase 1/2, Randomized, Observer-blind Study of Varying Injection Schedules of a Tetravalent Dengue Virus Purified Inactivated Vaccine (TDENV-PIV) With AS03B Adjuvant and Placebo in Healthy Adults in the US
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs TDENV PIV (Primary) ; AS03B
- Indications Dengue
- Focus Adverse reactions; Pharmacodynamics
- 24 Sep 2019 Status changed from recruiting to completed.
- 14 Aug 2018 Planned primary completion date changed from 15 Jun 2018 to 1 Jun 2019.
- 12 Oct 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.